Eli Lilly's Zepbound Gets FDA OK for Multi-Dose Pen
Eli Lilly's Zepbound Gets FDA OK for Multi-Dose Pen is drawing significant interest across the industry.
By Connor Hart Eli Lilly received approval from the Food and Drug Administration for a label expansion of its weight-loss drug Zepbound, adding a new monthly delivery option for patients. The...
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- Pune viral video: Father beats up alleged harasser of his daughter near MIT ADT campus
- Which City Is Called Garden City of India? Complete Travel Guide with Must-Dos, Best Food & How to Reach
- 'Dhurandhar 2 Can Permanently Destroy Pan
- in issues across India due to software problem
Source: Original →